AcuraStem

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including ALS and frontotemporal dementia. Utilizing its proprietary iNeuroRx® platform, AcuraStem creates patient-derived disease models that accurately reflect the complexities of these conditions. By integrating advanced AI techniques, the company aims to identify effective therapeutics tailored to individual patient needs, enhancing the potential for successful treatment outcomes in neurodegeneration.